日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease

FibroScan、FIB-4 和非酒精性脂肪性肝病纤维化评分在预测代谢功能障碍相关脂肪肝患者各纤维化阶段的活检定义的纤维化和脂肪变性方面的准确性

Thallapureddy, Keerthi; Twitchell, David; Ott, Kristen; Pedicone, Lisa D; Owo, Chioma; Kumar, Nina; Gelfond, Jonathan; Shankar, Nagasri; Goros, Martin; Kwok, Daisy; Liles, Anna; Ozguc, Fatma; Kazi, Iqra; Nguyen, Harry; Lawitz, Eric; Tsai, Eugenia; Rodas, Fabian; Landaverde, Carmen E; Poordad, Fred

Microglial ADGRG1/GPR56 regulates amyloid clearance in Alzheimer’s disease

小胶质细胞ADGRG1/GPR56调节阿尔茨海默病中的淀粉样蛋白清除

Nissen, Nicholas N; Menon, Vijay; Bresee, Catherine; Tran, Tram T; Annamalai, Alagappan; Poordad, Fred; Fair, Jeffrey H; Klein, Andrew S; Boland, Brendan; Colquhoun, Steven D; Zhu, Beika; Wangzhou, Andi; Yu, Diankun; Li, Tao; Schmidt, Rachael; De Florencio, Stacy L; Chao, Lauren; Seeley, William W; Piao, Xianhua

High sustained virologic response rates, regardless of race or socioeconomic class, in patients treated with chronic hepatitis C in community practice using a specialized pharmacy team

在社区医疗实践中,由专业药房团队治疗慢性丙型肝炎患者,无论种族或社会经济阶层如何,均可获得较高的持续病毒学应答率。

Kuwelker, Saatchi; Tsai, Eugenia; Kuo, Lily; Kim, Jae; Van Frank, Timothy; Mitchell, Robert; Ramirez, Ruben; Guerrero, Richard; Hanysak, Bryan; Landaverde, Carmen; Rodas, Fabian; Lawitz, Eric; Basra, Tamneet; Nguyen, Harry; Christensen, Kim; Vaughn, Clarissa; Hinojosa, Kim; Olvera, Nina; Caraballo-Gonzalez, Edna; Pham, Emma; Pedicone, Lisa D; Poordad, Fred

Pivoting to telemedicine in a single-day multidisciplinary liver tumor clinic during COVID-19: the Texas Liver Tumor Center experience

疫情期间,德克萨斯肝肿瘤中心如何在一日多学科肝肿瘤诊疗中转型远程医疗:经验总结

Crow, Katherine S; Poordad, Fred F; Halff, Glenn A; Cigarroa, Francisco G; Tsai, Eugenia; Infante, Irma V; Arora, Sukeshi Patel

BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial

BMS-986263治疗晚期肝纤维化患者:一项随机、安慰剂对照的II期试验的36周结果

Lawitz, Eric J; Shevell, Diane E; Tirucherai, Giridhar S; Du, Shuyan; Chen, Warner; Kavita, Uma; Coste, Angie; Poordad, Fred; Karsdal, Morten; Nielsen, Mette; Goodman, Zachary; Charles, Edgar D

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Aramchol治疗非酒精性脂肪性肝炎患者:一项随机、双盲、安慰剂对照的2b期试验

Ratziu, V; de Guevara, L; Safadi, R; Poordad, F; Fuster, F; Flores-Figueroa, J; Arrese, M; Fracanzani, Anna L; Ben Bashat, D; Lackner, K; Gorfine, T; Kadosh, S; Oren, R; Halperin, M; Hayardeny, L; Loomba, R; Friedman, S; Sanyal, Arun J

The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin

美国目前肝肾综合征-急性肾损伤的治疗现状及特利加压素的潜在应用

Flamm, Steven L; Brown, Kimberly; Wadei, Hani M; Brown, Robert S Jr; Kugelmas, Marcelo; Samaniego-Picota, Milagros; Burra, Patrizia; Poordad, Fred; Saab, Sammy

Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

格卡瑞韦/哌仑他韦治疗HCV基因5/6型患者的疗效和安全性:一项2/3期研究的综合分析

Yao, Betty B; Fredrick, Linda M; Schnell, Gretja; Kowdley, Kris V; Kwo, Paul Y; Poordad, Fred; Nguyen, Kinh; Lee, Samuel S; George, Christophe; Wong, Florence; Gane, Edward; Abergel, Armand; Spearman, Catherine W; Nguyen, Tuan; Hung Le, Manh; Pham, Thuy Tt; Mensa, Federico; Asselah, Tarik

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study

西美普韦、达卡他韦和索非布韦治疗丙型肝炎病毒感染患者:开放标签 II 期 IMPACT 研究的长期随访结果

Lawitz, Eric; Poordad, Fred; Gutierrez, Julio A; Beumont, Maria; Beets, Greet; Vandevoorde, Ann; Remoortere, Pieter Van; Luo, Donghan; Vijgen, Leen; Eygen, Veerle Van; Gamil, Mohamed

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease

格卡瑞韦/哌仑他韦在患有慢性基因1-6型丙型肝炎病毒感染和代偿性肝病的成人中的安全性和药代动力学

Gane, Edward; Poordad, Fred; Zadeikis, Neddie; Valdes, Joaquin; Lin, Chih-Wei; Liu, Wei; Asatryan, Armen; Wang, Stanley; Stedman, Catherine; Greenbloom, Susan; Nguyen, Tuan; Elkhashab, Magdy; Wörns, Marcus-Alexander; Tran, Albert; Mulkay, Jean-Pierre; Setze, Carolyn; Yu, Yao; Pilot-Matias, Tami; Porcalla, Ariel; Mensa, Federico J